Security key
25253X207
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)
CUSIP: 25253X207
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Voting Common Shares, no par value
- Total 13F shares
- 3,993,298
- Total 13F value
- $14,891,858
- Share change
- +1,187,753
- Put/Call ratio
- 508%
- SEC-reported price per share
- $3.73
- Number of holders
- 34
- Value change
- +$4,430,787
- Number of buys
- 16
- Number of sells
- 9
- Shares outstanding
- 52,272,727
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
34
Top holders
10
DMAC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2022
Previous quarter: Q3 2021
DiaMedica Therapeutics Inc. SEC filings
DiaMedica Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 25253X207
Recent filing periods:
Ownership snapshot
Top reported holders of DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F
Lead comparable stake: 1.5%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 1.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
1.5%
Ikarian Capital, LLC
0.6%
JACOB ASSET MANAGEMENT OF NEW YOR...
0.53%
Manatuck Hill Partners, LLC
0.52%
Leon G. Cooperman
0.38%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
1.5%
|
$3,158,000
787,536 shares
|
— | 30 Sep 2021 |
| Ikarian Capital, LLC |
13F
Company
|
0.6%
|
$1,247,000
311,041 shares
|
— | 30 Sep 2021 |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC |
13F
Company
|
0.53%
|
$1,103,000
275,000 shares
|
— | 30 Sep 2021 |
| Manatuck Hill Partners, LLC |
13F
Company
|
0.52%
|
$1,095,000
273,100 shares
|
— | 30 Sep 2021 |
| Leon G. Cooperman |
13F
Individual
|
0.38%
|
$802,000
200,000 shares
|
— | 30 Sep 2021 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.32%
|
$672,000
167,763 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
34
Shares
3,993,298
Rows available
34
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
31
Q4 2021 holders
34
Holder diff
3
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend